Cell Therapy Technologies Market 2024-2028
The cell therapy technologies market is forecasted to grow by USD 5920.4 mn during 2023-2028, accelerating at a CAGR of 19.7% during the forecast period. The report on the cell therapy technologies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased investment in cell therapy, launch of cell and gene therapy facilities, and rising traction of car t-cell therapies.
Technavio's cell therapy technologies market is segmented as below:
- By Technology
- Somatic cell technologies
- Gene modification techniques
- Genome editing technologies
- Others
- By End-user
- Biopharmaceuticals and biotechnology companies
- CROs and CMOs
- Research institute and cell banks
- By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the mergers and acquisitions as one of the prime reasons driving the cell therapy technologies market growth during the next few years. Also, growth in automated cell therapy manufacturing and emphasis on novel technologies will lead to sizable demand in the market.
The report on the cell therapy technologies market covers the following areas:
- Cell Therapy Technologies Market sizing
- Cell Therapy Technologies Market forecast
- Cell Therapy Technologies Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell therapy technologies market vendors that include Avantor Inc., Becton Dickinson and Co., Bio Techne Corp., Corning Inc., Danaher Corp., Fresenius Kabi AG, FUJIFILM Irvine Scientific Inc., Korber Medipak Systems GmbH, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Revvity Inc., Sartorius AG, STEMCELL Technologies Inc., TERUMO BCT, INC, and Thermo Fisher Scientific Inc.. Also, the cell therapy technologies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.